“Is UnitedHealth Stock an Undervalued Stock to Buy Right Now? | UNH Stock Analysis”
UNH is a buy; management's margin recovery and raised FCF estimates support ~40% upside in 12-18 months.
2025 was a very bad year for UnitedHealth, as the company's management team underestimated the cost of customer service. At the end of the year and the beginning of 2026, the management team made several adjustments to comply with current conditions.
As analysts, we were expecting certain results as a result of those adjustments. The results turned out to be better than expected. Today, I have raised my estimates for the company's free cash flow to adapt to these better conditions.